Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RVMD
RVMD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RVMD News
Goldman Sachs' Hedge Fund VIP List Includes Micron Technology
3d ago
CNBC
Biotech Fund Sells Erasca Stake After 700% Rally
May 18 2026
Yahoo Finance
Boxer Capital Acquires $17.55 Million Stake in Corvus Pharmaceuticals
May 17 2026
Yahoo Finance
Revolution Medicines Q1 2026 Earnings Call Insights
May 07 2026
seekingalpha
Revolution (RVMD) Q1 2026 Earnings Transcript
May 06 2026
NASDAQ.COM
Revolution Medicines Reports Clinical Trial Results for Daraxonrasib
May 06 2026
Newsfilter
Analysis of XBI ETF Trading Dynamics
May 06 2026
NASDAQ.COM
Revolution Medicines, Inc. Gains Attention for Huge Upside Potential
May 02 2026
Yahoo Finance
FDA Approves Revolution Medicines' Cancer Therapy for Expanded Access
May 01 2026
seekingalpha
Erasca's Cancer Drug Trial Data Triggers Stock Plunge
Apr 28 2026
seekingalpha
Erasca's Cancer Therapy Trial Reports Treatment-Related Death
Apr 28 2026
stocktwits
Revolution Medicines Stock Soars 250% Despite No Revenue
Apr 27 2026
Fool
Revolution Medicines' Promising Drug Sparks Investor Excitement
Apr 27 2026
NASDAQ.COM
Revolution Medicines Updates Clinical Data on Daraxonrasib for Pancreatic Cancer
Apr 22 2026
NASDAQ.COM
Revolution Medicines Releases Clinical Data on Daraxonrasib
Apr 21 2026
Newsfilter
Revolution Medicines Presents Phase 3 Trial Results for Daraxonrasib
Apr 21 2026
Newsfilter
Show More News
